(LOSS) EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Earnings Per Share [Abstract]
Net (loss) income attributable to Valeant Pharmaceuticals International, Inc.	$ (53.0)	$ 125.8	$ 20.7	$ 103.2
Basic weighted-average number of common shares outstanding	344.4	335.3	340.5	335.1
Diluted effect of stock options, RSUs and other (in shares)	0.0	6.0	6.6	6.3
Diluted weighted-average number of common shares outstanding	344.4	341.3	347.1	341.4
(Loss) earnings per share attributable to Valeant Pharmaceuticals International, Inc.:
Basic (in usd per share)	$ (0.15)	$ 0.38	$ 0.06	$ 0.31
Diluted (in usd per share)	$ (0.15)	$ 0.37	$ 0.06	$ 0.30